Category: Finance
-
NIH Funds Programmable mRNA to Treat Cancer
National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of solid tumor cancer.
-
Sanofi Acquires mRNA Developer in $3.2B Deal
Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator.
-
Alzheimer’s Digital Biomarkers Project Gains New Funds
A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer’s disease and other forms of dementia.
-
Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds
A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds.
-
ALS Drug Maker Gains $135M in New Funds
A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round.
-
Infographic – 2021 Black Start-Up Funding Rises
Venture funding for Black-owned start-ups in the U.S. rose to record levels in the first half of 2021, but the percentage of total funding remains low.
-
Immune Cell Cancer Biotech Gains $172M in New Funds
A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round.
-
$60M Challenge Seeks RNA Bio-Production Network
A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products.
-
Precision Gene-Editing Biotech Gains $200M in New Funds
A biotechnology company says it discovers therapies with the gene-editing technique Crispr to carry out a wider range of precise genomic corrections.
-
Infographic – U.S. Leads Record Q2 Venture Funding
Venture capital financing broke global records in the second quarter of 2021, with investments in the U.S. accounting for nearly half of all dollars invested.